Stay updated on T-DXd Combos in HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the T-DXd Combos in HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd Combos in HER2+ MBC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new study involving Pertuzumab and Tucatinib for HER2-positive metastatic breast cancer, replacing the previous focus on trastuzumab deruxtecan. Key details about the study's phases and patient enrollment criteria have been clarified.
    Difference
    21%
    Check dated 2025-04-16T14:33:33.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 14, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T09:22:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 14, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T23:25:59.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T23:29:34.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing several past dates and adding new future dates, indicating a shift in the timeline of events or updates.
    Difference
    0.8%
    Check dated 2025-02-17T19:38:18.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T17:04:12.000Z thumbnail image

Stay in the know with updates to T-DXd Combos in HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd Combos in HER2+ MBC Clinical Trial page.